Partnering

Collaboration

With between 500 and 1500 human microRNAs, between 50 and 100 target mRNAs for each microRNA and different expression patterns of microRNAs, mRNA and co-factors in different cells, characterisation of microRNA regulatory pathways is an immense task.

However, identification of specific microRNA-mRNA interactions and subsequent decoding of the physiological relevance of single microRNA-mRNA interactions, is ongoing at a blistering pace - reflecting the priority the microRNA field has given the task of understanding microRNA regulatory pathways and how these may be modulated to treat diseases.

Mirrx is interested in collaborations with academic and industrial groups directed at single microRNA:mRNA interactions with an established therapeutic relevance as well as the identification of such microRNA:mRNA interactions.

Mirrx is looking to enter collaborations and partnerships with regards to the chemistry and delivery of blockmirs.



Licensing

Mirrx believes in an active licensing strateg and we welcome inquiries regarding access to our fundamental IP based on licenses for specific targets and/or indications. Moreover, Mirrx is interested in licensing specific opportunities, e.g. related to specific microRNA-mRNA interactions.